Courtenay Gilmore Wilson
Biographic Data
| ID | 8926449 |
|---|---|
| NAME | Courtenay Gilmore Wilson |
| GIVEN NAMES | Courtenay Gilmore |
| FAMILY NAME | Wilson |
| SIGNATURE | WILSON C G |
| AFFILIATIONS | University of North Carolina (UNC) Health Sciences at Mountain Area Health Education Center (MAHEC) Asheville North Carolina |
| ORCID | 0000-0002-4634-7013 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2021 |
| H-INDEX | 0 |
An examination of telehealth policy impacts on initial rural opioid use disorder treatment patterns during the Covid‐19 pandemic
PURPOSE: Tracking changes in care utilization of medication for opioid use disorder (MOUD) services before, during, and after COVID-19-associated changes in policy and service delivery in a mixed rural and micropolitan setting. METHODS: Using a retrospective, open-cohort design, we examined visit data of MOUD patients at a family medicine clinic across three identified periods: pre-COVID, COVID transition, and COVID. Outcome measures include the …
A Primary Care Response to Covid‐19 for Patients with an Opioid Use Disorder
The Coronavirus Disease of 2019 (COVID-19) has prompted adaptations and restructuring of almost every institution in the nation. While these efforts to mitigate the spread of COVID-19 affect everyone, patients treated with buprenorphine/naloxone for an opioid use disorder (OUD) will feel these disruptions more acutely, especially in rural communities. Many of our patients rely on hourly employment, which has been reduced or eliminated. School sys…
No prominent works on this page.
An examination of telehealth policy impacts on initial rural opioid use disorder treatment patterns during the Covid‐19 pandemic
PURPOSE: Tracking changes in care utilization of medication for opioid use disorder (MOUD) services before, during, and after COVID-19-associated changes in policy and service delivery in a mixed rural and micropolitan setting. METHODS: Using a retrospective, open-cohort design, we examined visit data of MOUD patients at a family medicine clinic across three identified periods: pre-COVID, COVID transition, and COVID. Outcome measures include the …
A Primary Care Response to Covid‐19 for Patients with an Opioid Use Disorder
The Coronavirus Disease of 2019 (COVID-19) has prompted adaptations and restructuring of almost every institution in the nation. While these efforts to mitigate the spread of COVID-19 affect everyone, patients treated with buprenorphine/naloxone for an opioid use disorder (OUD) will feel these disruptions more acutely, especially in rural communities. Many of our patients rely on hourly employment, which has been reduced or eliminated. School sys…
Family medicine (2 works) · Internal Medicine (2 works) · Medicine (2 works) · Opioid (2 works) · Opioid use disorder (2 works) · Opioid Use Disorder Treatment (2 works) · 2019-20 coronavirus outbreak (1 work) · COVID-19 and Mental Health (1 work) · Demography (1 work) · Disease (1 work)